Skip to the page

Data / Form D filings / THERALASE TECHNOLOGIES INC /FI

THERALASE TECHNOLOGIES INC /FI: Form D filings

THERALASE TECHNOLOGIES INC /FI, a company in Toronto, Ontario, Canada, filed 5 Form D notices with the SEC between 2018 and 2026. The latest, on August 31, 2026, reports $72,298 sold of a $168,695 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
41 Hollinger Road, Toronto, Ontario, Canada, M4B 3
Phone
(416) 699-5273
Industry
Other
Entity type
Corporation
Incorporated in
Ontario, Canada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
923883

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 31, 2026New notice$168,695$72,298$96,3971Aug 24, 2026sec.gov
May 27, 2026New notice$262,156$109,080$153,0761May 20, 2026sec.gov
Sep 10, 2019New notice$700,892$323,489$377,4033Aug 22, 2019sec.gov
Oct 19, 2018New notice$160,109$160,1094Oct 3, 2018sec.gov
May 29, 2018New notice$62,622$62,6223May 14, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Roger Dumoulin-WhiteExecutive Officer, Director
Kristina HacheyExecutive Officer, Director
Arkady MandelExecutive Officer, Director
Matthew PerratonDirector
Randy BruderDirector
Kaouthar LbiatiDirector
Guy AndersonDirector

Every Form D from the week of Aug 31, 2026 · All recent Other filings

Read from SEC EDGAR. Amount sold is what THERALASE TECHNOLOGIES INC /FI reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.